Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Prednisolon ohne Tabletten der Packungsgröße größer 50 Stück (ATC Code WHO: H02AB06).

Conclusion of a non-exclusive rebate contract pursuant to § 130a para. 8 SGB V for the prescription and dispensing of medicines with the active substance Prednisolone, excluding tablets in packs of more than 50 units (ATC Code WHO: H02AB06) within the period from 01.11.2026 to 31.10.2028, with the possibility of concluding the contract at any time during the contract period ("open-house model"). In Niedersachsen, pharmacies must prioritise dispensing finished medicinal products for which a rebate contract pursuant to § 130a para. 8 SGB V exists, even in the case of prescription requirements, as of 01.07.2026.